TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Torrent Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here TORRENT PHARMACEUTICALS LTD. - 500420 - Scrutiniser''s Report On The Postal Ballot
This refers to the Postal Ballot Notice dated 25th May, 2022 sent to the shareholders of the Company seeking their approval on the items as detailed in the Notice. The e-voting facility to shareholders was provided through Central Depository Services (India) Limited. Thee-voting period commenced on Wednesday, 1st June, 2022 from 9.00 am and ended on Thursday, 30th June, 2022 at 5.00 pm. Rajesh Parekh, Practicing Company Secretary & Scrutinizer, appointed by the Board, has submitted his report on the result of Postal Ballot and based on the said report Samir Mehta, Chairman has announced the results of the Postal Ballot, copy of the same is enclosed herewith. The results of the postal ballot under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") is being submitted separately. TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement - Intimation of the 49th Annual General Meeting of the Company through Video-Conferencing / Other Audio Visual Means ('VC / OAVM') facility TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Monday, 11th July, 2022 as the Record Date for the purpose of determining the names of Members who shall be entitled for allotment of bonus equity shares in the ratio of 1:1 i.e. 1 (One) new fully paid-up equity share of ? 5/- each for every 1 (One) fully paid-up equity share of ? 5/- each held by the existing Members of the Company. TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st July, 2022 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th June, 2022 to the Stock Exchanges.
Strong domestic outlook remains key growth driver for Torrent Pharma
Cost savings could drive Torrent Pharma's margins higher in the near term TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of the transfer of shares to IEPF TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for completion of dispatch of Postal Ballot Notice